1.
Goričar K, Kovač V, Dolžan V. The influence of folate pathway polymorphisms on pemetrexed treatment outcome in patients with malignant mesothelioma. RO [Internet]. 2014May9 [cited 2021Apr.21];48(2). Available from: https://radioloncol.com/index.php/ro/article/view/2043